X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB LUPIN LTD UNICHEM LAB/
LUPIN LTD
 
P/E (TTM) x -276.4 164.3 - View Chart
P/BV x 2.0 3.1 66.7% View Chart
Dividend Yield % 1.3 0.8 153.0%  

Financials

 UNICHEM LAB   LUPIN LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
LUPIN LTD
Mar-17
UNICHEM LAB/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs3201,750 18.3%   
Low Rs2211,384 16.0%   
Sales per share (Unadj.) Rs167.2387.4 43.2%  
Earnings per share (Unadj.) Rs12.056.6 21.1%  
Cash flow per share (Unadj.) Rs16.976.8 22.0%  
Dividends per share (Unadj.) Rs3.007.50 40.0%  
Dividend yield (eoy) %1.10.5 231.7%  
Book value per share (Unadj.) Rs117.0298.9 39.2%  
Shares outstanding (eoy) m90.88451.58 20.1%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x1.64.0 40.0%   
Avg P/E ratio x22.627.7 81.7%  
P/CF ratio (eoy) x16.020.4 78.3%  
Price / Book Value ratio x2.35.2 44.1%  
Dividend payout %25.113.2 189.4%   
Avg Mkt Cap Rs m24,578707,513 3.5%   
No. of employees `0005.216.8 30.9%   
Total wages/salary Rs m2,48728,495 8.7%   
Avg. sales/employee Rs Th2,928.310,418.3 28.1%   
Avg. wages/employee Rs Th479.41,697.0 28.2%   
Avg. net profit/employee Rs Th209.41,523.0 13.8%   
INCOME DATA
Net Sales Rs m15,195174,943 8.7%  
Other income Rs m1101,065 10.3%   
Total revenues Rs m15,305176,008 8.7%   
Gross profit Rs m1,78844,931 4.0%  
Depreciation Rs m4529,122 5.0%   
Interest Rs m341,525 2.2%   
Profit before tax Rs m1,41335,349 4.0%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3269,785 3.3%   
Profit after tax Rs m1,08725,575 4.2%  
Gross profit margin %11.825.7 45.8%  
Effective tax rate %23.127.7 83.3%   
Net profit margin %7.214.6 48.9%  
BALANCE SHEET DATA
Current assets Rs m6,426119,542 5.4%   
Current liabilities Rs m3,91761,206 6.4%   
Net working cap to sales %16.533.3 49.5%  
Current ratio x1.62.0 84.0%  
Inventory Days Days6876 89.0%  
Debtors Days Days7790 85.7%  
Net fixed assets Rs m7,410131,660 5.6%   
Share capital Rs m182903 20.1%   
"Free" reserves Rs m10,454134,073 7.8%   
Net worth Rs m10,636134,976 7.9%   
Long term debt Rs m456,478 0.0%   
Total assets Rs m15,258266,073 5.7%  
Interest coverage x42.924.2 177.5%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x1.00.7 151.5%   
Return on assets %7.310.2 72.1%  
Return on equity %10.218.9 53.9%  
Return on capital %13.619.3 70.6%  
Exports to sales %24.10-   
Imports to sales %4.90-   
Exports (fob) Rs m3,666NA-   
Imports (cif) Rs m752NA-   
Fx inflow Rs m5,29881,885 6.5%   
Fx outflow Rs m021,506 0.0%   
Net fx Rs m5,29860,378 8.8%   
CASH FLOW
From Operations Rs m68341,148 1.7%  
From Investments Rs m-1,316-25,287 5.2%  
From Financial Activity Rs m5924,332 13.7%  
Net Cashflow Rs m-4020,193 -0.2%  

Share Holding

Indian Promoters % 50.1 46.6 107.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 15.1 11.3 133.6%  
FIIs % 3.0 31.9 9.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.1 313.9%  
Shareholders   20,176 98,259 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  GSK PHARMA  PLETHICO PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 25, 2018 03:31 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - DISHMAN PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS